Evaluation of cabozantinib in combination with abiraterone, enzalutamide or docetaxel in a castration-resistant prostate cancer xenograft in vivo

被引：0
|
作者：
Nguyen, Holly M. [1 ]
Brown, Lisha G. [1 ]
Olson, Jessica L. [1 ]
Aftab, Dana T. [2 ]
Vessella, Robert L. [1 ]
Corey, Eva [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Exelixis Inc, San Francisco, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
735
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
    Schrader, Andres Jan
    Boegemann, Martin
    Ohlmann, Carsten-H.
    Schnoeller, Thomas J.
    Krabbe, Laura-Maria
    Hajili, Turkan
    Jentzmik, Florian
    Stoeckle, Michael
    Schrader, Mark
    Herrmann, Edwin
    Cronauer, Marcus V.
    EUROPEAN UROLOGY, 2014, 65 (01) : 30 - 36
  • [2] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Schmid, Sebastian Christoph
    Geith, Alexander
    Boeker, Alena
    Tauber, Robert
    Seitz, Anna Katharina
    Kuczyk, Markus
    von Klot, Christoph
    Gschwend, Juergen Erich
    Merseburger, Axel Stuart
    Retz, Margitta
    ADVANCES IN THERAPY, 2014, 31 (02) : 234 - 241
  • [3] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sebastian Christoph Schmid
    Alexander Geith
    Alena Böker
    Robert Tauber
    Anna Katharina Seitz
    Markus Kuczyk
    Christoph von Klot
    Jürgen Erich Gschwend
    Axel Stuart Merseburger
    Margitta Retz
    Advances in Therapy, 2014, 31 : 234 - 241
  • [4] Continuing enzalutamide with docetaxel in castration-resistant prostate cancer
    Shiota, Masaki
    LANCET ONCOLOGY, 2022, 23 (11): : 1345 - 1347
  • [5] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [6] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [7] Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
    Cheng, H. H.
    Gulati, R.
    Azad, A.
    Nadal, R.
    Twardowski, P.
    Vaishampayan, U. N.
    Agarwal, N.
    Heath, E. I.
    Pal, S. K.
    Rehman, H-t
    Leiter, A.
    Batten, J. A.
    Montgomery, R. B.
    Galsky, M. D.
    Antonarakis, E. S.
    Chi, K. N.
    Yu, E. Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (02) : 122 - 127
  • [8] Antitumor activity of abiraterone, enzalutamide, and docetaxel following treatment with diethystilbestrol in castration-resistant prostate cancer.
    Assoun, Sandra
    Campedel, Luca
    Roupret, Morgan
    Vaessen, Christophe
    Parra, Jerome
    Boostandoost, Haide Angele
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [9] Efficacy of sequential therapy comprising of docetaxel, abiraterone, enzalutamide, and cabazitaxel in patients with castration-resistant prostate cancer
    Yamamoto, Akiyuki
    Kato, Masashi
    Tsuzuki, Toyonori
    Gotoh, Momokazu
    Naito, Yushi
    Hattori, Kyosuke
    Tochigi, Kosuke
    Yuba, Takuma
    Kawanishi, Hideji
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Clinical Activity of Enzalutamide Versus Docetaxel in Men With Castration-Resistant Prostate Cancer Progressing After Abiraterone
    Suzman, Daniel L.
    Luber, Brandon
    Schweizer, Michael T.
    Nadal, Rosa
    Antonarakis, Emmanuel S.
    PROSTATE, 2014, 74 (13): : 1278 - 1285
12345